Cross-cohort insights into the association of handgrip strength transitions and burdens with cardiovascular disease risk

This multi-cohort study demonstrates that longitudinal transitions and cumulative burdens of handgrip strength are stronger predictors of incident cardiovascular disease risk than single baseline measurements, particularly in East Asian populations, highlighting the clinical value of monitoring dynamic changes in muscle strength for CVD prevention.

The Gist

The Big Picture: Your Grip is a Crystal Ball

Imagine your handgrip strength (how hard you can squeeze) isn't just about how strong your arms are. Think of it as a canary in a coal mine or a dashboard warning light for your entire body, especially your heart.

For years, doctors have known that if your grip is weak, your risk of heart disease is higher. But this study asked a new, more dynamic question: It's not just about how strong you are today; it's about whether you are getting stronger or weaker over time.

The Study: A Global Team Up

The researchers didn't just look at one group of people. They acted like a massive detective team, combining data from four different countries:

1. UK (The UK Biobank)
2. China (CHARLS)
3. Europe (SHARE)
4. Korea (KLOSA)

They tracked over 73,000 people for several years. Instead of just taking one snapshot of their grip strength, they took a "movie" of it, measuring it at the start and then again a few years later.

The Main Discovery: The "Grip Trajectory" Matters

The study found that your grip strength journey tells a much bigger story than a single measurement.

• The "Falling" Grip: If your grip strength started okay but then dropped over time, your risk of heart disease skyrocketed. It's like a car engine that starts making a knocking sound and gets worse every week; the engine (your heart) is in trouble.
• The "Rising" Grip: If your grip strength improved over time, your risk of heart disease went down. It's like tuning up your engine; getting stronger actually protects your heart.
• The "Stable" Grip: Keeping your grip steady is good, but getting stronger is even better.

The "Burden" Analogy: It's About the Rain, Not Just the Puddle

The researchers invented three new ways to measure grip strength, which they called "Burdens." Here is how to understand them:

1. The Slope (The Speed of the Fall): Imagine a hill. If you are sliding down a steep hill (your grip dropping fast), that is dangerous. If you are sliding down a gentle slope, it's less risky. The study found that the faster your grip drops, the higher your heart risk.
2. The Cumulative Load (The Total Rainfall): Imagine it's raining on your roof. A single drop (one measurement) doesn't tell you much. But if it rains heavily for years (low grip strength over a long time), your roof leaks. The study found that the total amount of time you spent with weak grip strength is a huge predictor of heart trouble.
3. The Relative Change (The Comparison): This looks at how much you've changed compared to where you started. If you started strong and got weak, that "loss" is a heavy burden on your heart.

The Big Surprise: These "burdens" (the history of your strength) were actually better at predicting heart attacks than just looking at your grip strength on the day of the test. It's like a weather forecast based on a week of data is better than looking out the window for 5 seconds.

The East Asian vs. European Difference

The study found an interesting twist based on where people lived:

• East Asian cohorts (China & Korea): The link between losing grip strength and heart disease was much stronger.
• European cohorts (UK & Europe): The link was still there, but slightly weaker.

Why? The researchers suggest it might be because East Asians often have less muscle mass to begin with. So, when an East Asian person loses a little bit of grip strength, it might signal a more severe loss of muscle health (sarcopenia) compared to Europeans, making it a louder "alarm bell" for their heart.

The "Scorecard" Upgrade

Finally, the researchers asked: "Can we use this to predict heart attacks better?"

They took a standard heart risk calculator (called SCORE2) and added the grip strength data to it.

• The Result: Adding the grip strength history (especially the "cumulative burden") made the prediction tool significantly more accurate.
• The Metaphor: Imagine you are trying to guess if a car will break down. You look at the mileage (standard risk factors). Now, imagine you also look at the history of the engine's vibration (grip strength history). Suddenly, your guess becomes much more accurate.

The Takeaway for You

1. Don't just check your strength once. If you are getting weaker, that is a warning sign to pay attention to your heart.
2. Getting stronger is medicine. If you can improve your grip strength through exercise, you might actually be lowering your heart disease risk.
3. It's a simple test. You don't need an MRI or a blood test to get a hint about your heart health. A simple handgrip dynamometer (a small device you squeeze) can tell a powerful story about your future health.

In short: Your hands are talking to your heart. If they are getting weaker, listen to them. If you can make them stronger, your heart will thank you.

Technical Summary

1. Problem Statement

While previous research has established Handgrip Strength (HGS) as a static predictor of Cardiovascular Disease (CVD) risk, significant gaps remain in the current literature:

• Static vs. Dynamic: Most studies rely on a single baseline measurement, ignoring longitudinal changes (trajectories) in muscle strength over time.
• Lack of Cross-Population Validation: Findings are often limited to single cohorts, with insufficient evidence regarding racial/ethnic differences (specifically between European and East Asian populations).
• Incomplete Metrics: Existing studies often use a single dynamic indicator (e.g., slope) rather than systematically integrating multiple dimensions of dynamic exposure (rate of change, cumulative load, and relative deviation).
• Predictive Utility: It is unclear whether incorporating dynamic HGS metrics improves upon established risk scores like SCORE2.

2. Methodology

Data Sources & Study Design

• Cohorts: The study analyzed data from four large-scale prospective cohorts:
  • European: UK Biobank (UKB) and Survey of Health, Ageing and Retirement in Europe (SHARE).
  • East Asian: China Health and Retirement Longitudinal Study (CHARLS) and Korean Longitudinal Study of Ageing (KLOSA).
• Sample Size: 73,555 participants (46,958 UKB, 26,167 SHARE, 5,804 CHARLS, 4,626 KLOSA).
• Follow-up: Baseline ($t_0$) and first follow-up ($t_1$) for HGS measurements (approx. 2-year intervals), with a final follow-up for CVD events.
• Inclusion/Exclusion: Included White European and East Asian ancestry; excluded those with baseline CVD, missing HGS data, or loss to follow-up.

Variable Definitions

• Outcome: Incident CVD (composite of coronary heart disease, heart failure, atrial fibrillation, or stroke).
• Exposure (HGS): Measured using a Jamar dynamometer. Defined as the mean of left/right hands adjusted for body weight (relative HGS) to account for body size differences.
• HGS Transitions: Categorized based on tertiles (Low, Moderate, High) at $t_0$ and $t_1$ (e.g., Low $\to$ Low, Low $\to$ Increased, High $\to$ Decreased).
• HGS Burdens (Dynamic Indicators): Three continuous metrics calculated between $t_0$ and $t_1$:
  1. HGS Slope: Rate of change ($HGS_1 - HGS_0$) / time.
  2. Cumulative HGS: Area under the curve (total exposure).
  3. Relative Cumulative HGS: Cumulative HGS relative to baseline.

Statistical Analysis

• Association: Cox proportional hazards models adjusted for covariates (age, sex, education, income, smoking, alcohol, physical activity, diabetes, hypertension, BMI).
• Meta-analysis: Random-effect or fixed-effect models pooled results across cohorts based on heterogeneity (Cochran's Q).
• Prediction Modeling:
  • Compared a base model (SCORE2) against models adding HGS and its dynamic burdens.
  • Utilized four machine learning algorithms: Logistic Regression, Random Forest, XGBoost, and LightGBM.
  • Evaluated performance via AUC, Net Reclassification Improvement (NRI), and Integrated Discrimination Improvement (IDI).
• Sensitivity Analyses: Excluded early events (reverse causality), adjusted for medication use, and used Fine-Gray models for competing risks (death).

3. Key Contributions

• Longitudinal Framework: Shifted the paradigm from static HGS assessment to dynamic trajectory analysis (transitions and burdens).
• Cross-Ethnic Validation: Provided robust evidence across four distinct cohorts, explicitly comparing European and East Asian populations.
• Multi-Dimensional Metrics: Introduced and validated three distinct HGS burden indicators (slope, cumulative, relative cumulative) to capture different aspects of muscle health exposure.
• Clinical Integration: Demonstrated the incremental predictive value of adding dynamic HGS metrics to the widely used SCORE2 algorithm.

4. Key Results

HGS Transitions and CVD Risk

• General Trend: Increasing HGS during follow-up reduced CVD risk, while decreasing HGS elevated risk.
  • Low $\to$ Increased: 28.3% lower risk.
  • High $\to$ Decreased: 31.2% higher risk.
• Ethnic Differences: The risk associated with declining HGS was significantly stronger in East Asian cohorts.
  • Moderate $\to$ Low: 87.6% risk increase in East Asians vs. non-significant in Europeans.
  • High $\to$ Decreased: 122.2% risk increase in East Asians vs. non-significant in Europeans.

HGS Burdens and CVD Risk

• Independent Effect: HGS burdens remained significant predictors even after adjusting for baseline HGS.
• Magnitude of Risk (per SD decrement):
  • HGS Slope: 19.8% increased risk.
  • Cumulative HGS: 44.0% increased risk (strongest effect).
  • Relative Cumulative HGS: 26.7% increased risk.
• Comparison: HGS burdens consistently showed stronger associations with CVD than baseline HGS alone.
• Ethnic Heterogeneity: Effects were more pronounced in East Asian cohorts (e.g., HGS slope HR in KLOSA was 1.43 vs. 1.11 in SHARE).

Predictive Performance

• European Cohorts: Adding HGS burdens to SCORE2 improved AUC by up to 7.6% (LightGBM model). Relative cumulative HGS provided the largest single gain (3.8%).
• East Asian Cohorts: Adding HGS burdens improved AUC by up to 5.9% (Random Forest model).
• Reclassification: Significant improvements in NRI and IDI were observed, particularly for the full models (S5) combining all metrics.

5. Significance and Implications

• Clinical Utility: The study suggests that longitudinal monitoring of HGS is superior to single-time-point measurements for CVD risk stratification. The "burden" of muscle weakness over time is a more potent predictor than a static snapshot.
• Public Health Strategy: HGS is a low-cost, non-invasive marker. Integrating dynamic HGS tracking into primary care could help identify high-risk individuals earlier, especially in East Asian populations where the risk amplification is greater.
• Reversibility: The finding that increasing HGS reduces risk supports the concept that muscle health is modifiable and that interventions to preserve or improve strength can mitigate CVD risk.
• Risk Modeling: Incorporating dynamic muscle metrics into standard algorithms (like SCORE2) significantly enhances their discriminatory power, offering a cost-effective way to refine global CVD prevention strategies.

Limitations Noted:

• Potential residual confounding from medication use and comorbidities.
• Heterogeneity in CVD definition (ICD codes in UKB vs. self-report in others).
• Measurement variability in HGS (though minimized by standardization and averaging).

Conclusion:
Dynamic HGS trajectories and cumulative burdens are independent, robust predictors of CVD risk, outperforming static HGS measurements. These effects are particularly strong in East Asian populations, highlighting the need for ethnicity-specific risk assessment strategies that prioritize longitudinal muscle function monitoring.